Renoprotective effect of the L/N-type calcium channel antagonist cilnidipine on puromycin aminonucleoside-induced nephrosis in rats. (Record no. 18773833)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02000 a2200565 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250515164413.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 200904s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 0004-4172 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1055/s-0031-1296368 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Takashima, Kayoko |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20090428 |
| 245 00 - TITLE STATEMENT | |
| Title | Renoprotective effect of the L/N-type calcium channel antagonist cilnidipine on puromycin aminonucleoside-induced nephrosis in rats. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | Arzneimittel-Forschung |
| Date of publication, distribution, etc. | 2009 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 79-85 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Journal Article |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Angiotensin-Converting Enzyme Inhibitors |
| General subdivision | therapeutic use |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Animals |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antimetabolites, Antineoplastic |
| General subdivision | toxicity |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Blood Pressure |
| General subdivision | drug effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Calcium Channel Blockers |
| General subdivision | therapeutic use |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Calcium Channels, L-Type |
| General subdivision | drug effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Calcium Channels, N-Type |
| General subdivision | drug effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Creatinine |
| General subdivision | blood |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Dihydropyridines |
| General subdivision | therapeutic use |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Enalapril |
| General subdivision | therapeutic use |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Fluorescent Antibody Technique |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Male |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Membrane Proteins |
| General subdivision | biosynthesis |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Nephrosis |
| General subdivision | chemically induced |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Protective Agents |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Proteinuria |
| General subdivision | prevention & control |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Puromycin Aminonucleoside |
| General subdivision | toxicity |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Rats |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Rats, Sprague-Dawley |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Nishiyama, Chizuru |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Arisaka, Nobuhiko |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Takahashi, Tetsuaki |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Souma, Shinji |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Tsuda, Miyuki |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Hayashi, Morimichi |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Kasahara, Hiroko |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Kodama, Hirokazu |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Tamura, Toru |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Murakami, Makoto |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Kuroda, Junji |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Sato, Fumiyasu |
| 773 0# - HOST ITEM ENTRY | |
| Title | Arzneimittel-Forschung |
| Related parts | vol. 59 |
| -- | no. 2 |
| -- | p. 79-85 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1055/s-0031-1296368">https://doi.org/10.1055/s-0031-1296368</a> |
| Public note | Available from publisher's website |
No items available.